how long have glp-1 been around medications are transforming diabetes and weight loss treatment How Long for GLP-1 to

Crucially, this action is glucose-dependent, meaning it primarily happens when blood sugar levels are high, such as after a meal

Comorbidities: Type 2 diabetes: Both are FDA-approved for diabetes (tirzepatide as Mounjaro, semaglutide as Ozempic) Cardiovascular disease: Semaglutide has the cardiovascular outcomes data Sleep apnea: Tirzepatide has shown benefits Injection frequency: Both are once-weekly

Caution is Required During Active Chemotherapy and Immunotherapy While the benefits in the survivorship setting are promising, Iyengar highlighted a note of caution for patients currently undergoing intensive active treatment

Even the best possible response to medication is unlikely to produce enough weight loss, he says

Retatrutide is the only late-stage compound that provides significant glucagon receptor activation alongside GLP-1 and GIP agonism

Recent study results shared at the Endocrine Society meeting ENDO 2026 indicate that semaglutide was linked to higher weight loss and a 15% decrease in broken bones when it was compared to other weight loss medications